Jean Selden Greene serves as Executive at Amneal Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jean Selden Greene has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 8, 2019 involved exercising options for 6,107 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 8, 2019 | AMRX | $0 | Option Exercise | 6,107 | $N/A | Discretionary |
Jean Selden Greene currently holds 6,107 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jean Selden Greene has been a net neutral trader of AMRX stock. They have purchased $0 and sold $0 worth of shares.
Jean Selden Greene's most recent insider trade was on May 8, 2019, when they sold 6,107 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted